| Patient | Florence Nightingale |
|---|---|
| Date of birth | 1988-05-12 |
| Identifiers | MRN HR-NI004-SYN; SSN (made up) 000-04-9271 |
| Document date | 2026-03-16 |
| Author | Isobel Marchetti, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Review of exclusion tests and ME/CFS care plan. [S]
Ms. Nightingale returns two weeks after her first visit to review her tests, and saw the infectious diseases physician this morning. She has kept the activity and symptom diary we agreed on. It shows the pattern she described: on days she works more than about three hours or goes out, she feels worse the next day or the day after, with aches as if she had the flu, heavier fatigue, and poor concentration that take two to four days to settle. She sleeps nine hours but wakes unrefreshed. Standing at the stove or in a line still makes her lightheaded with a pounding heart within a few minutes. She has started drinking more fluid, about 1.8 L a day. She takes acetaminophen two or three times a week for muscle aches and headache. Her mood is frustrated but not low, and she has no thoughts of self-harm. [S]
| Element | Detail |
|---|---|
| Interval change | No change; diary confirms delayed post-exertional malaise lasting two to four days |
| Sleep | Nine hours, unrefreshing |
| Orthostatic symptoms | Lightheaded with palpitations within minutes of standing |
| Pain | Muscle aches and headache; acetaminophen two or three times a week |
| Function | Working about three hours a day, reclined |
| Mood | Frustrated, not depressed; no thoughts of self-harm |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Fatigue worsened by activity; no fever, night sweats, or weight loss |
| Cardiovascular | Positive | Palpitations and lightheadedness on standing; no chest pain or syncope |
| Musculoskeletal | Positive | Diffuse muscle aches; no localized back, hip, or joint pain or swelling |
| Neurological | Positive | Poor concentration and word-finding after exertion; headaches; no weakness or numbness |
| Psychiatric | Negative | No low mood, anhedonia, or thoughts of self-harm |
| Gastrointestinal | Negative | No diarrhea, abdominal pain, or bleeding |
6 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one to two tablets by mouth every 6 hours as needed for muscle pain or headache, no more than 3 g a day | One to two tablets by mouth every 6 hours as needed; no more than 3 g a day | Oral route | 2025-11-03 | active | S |
| Cholecalciferol (vitamin D3) 50 mcg (2,000 units) oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-16 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-16 | Body height | 170 | cm | S |
| 2026-03-16 | Body weight | 55.2 | kg | S |
| 2026-03-16 | Body mass index (BMI) [Ratio] | 19.1 | kg/m2 | S |
| 2026-03-16 | Systolic blood pressure | 106 | mm[Hg] | S |
| 2026-03-16 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 2026-03-16 | Heart rate | 76 | /min | S |
| 2026-03-16 | Respiratory rate | 14 | /min | S |
| 2026-03-16 | Body temperature | 36.5 | Cel | S |
| 2026-03-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
Vital signs recorded on 2026-03-16; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Alert and articulate; prefers to sit reclined |
| Lymph nodes | No lymphadenopathy |
| Heart | Regular rhythm; no murmur |
| Abdomen | No liver or spleen enlargement |
| Musculoskeletal | No spinal, sacroiliac, or joint tenderness; no synovitis; strength normal |
| Neurological | Normal tone, reflexes, and sensation |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Myalgic encephalomyelitis/chronic fatigue syndrome, post-infectious, moderate severity, with orthostatic intolerance; synthetic modern diagnosis by NICE and IOM criteria, linked to her documented Crimean fever and decades of illness, which are only retrospectively and disputedly read as ME/CFS | active | confirmed | G93.32 | S — Synthetic diagnosis made by clinical criteria after exclusion tests in the modern episode; the historical reading of her illness as ME/CFS remains R and disputed. |
| Personal history of brucellosis diagnosed by serology during an overseas field-hospital deployment and treated with six weeks of doxycycline and rifampin; no evidence of relapse | active | confirmed | Z86.19 | S — Synthetic history echoing the disputed retrospective interpretation of her Crimean fever as brucellosis; not a historical diagnosis. |
| Vitamin D deficiency | active | confirmed | E55.9 | S — Synthetic finding on the intake tests, reviewed at the two-week visit. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Exclusion tests for suspected ME/CFS | Once, at diagnosis | Completed today | Drawn at intake two weeks ago and reviewed today: blood count, metabolic panel, liver tests, calcium, phosphate, ESR, CRP, TSH, HbA1c, ferritin, coeliac antibody, creatine kinase, morning cortisol, B12, and folate all normal; 25-hydroxyvitamin D low at 17 ng/mL. The intake urine dipstick was negative for protein, blood, and glucose |
| Laboratory | Serological tests after a history of infection | By clinical judgment | Not indicated | Brucella serology was positive and treated abroad; agglutinating antibodies can persist for a long time after cure, so a repeat titer would not show relapse. Infectious diseases agrees; blood cultures only if fever returns |
| Examination | Ten-minute standing test for orthostatic intolerance | At diagnosis; repeat if symptoms change | Up to date | Done at intake: heart rate rise of 26/min, no orthostatic hypotension; repeat at the six-month review |
| Examination | Symptom review: post-exertional malaise, sleep, pain, cognition, and orthostatic symptoms | Every review | Completed today | Diary reviewed; all four core features present |
| Survey | PHQ-9 mood screen | At diagnosis and at each review | Up to date | 8 at intake, with item 9 scored 0; repeat at the three-month review |
| Survey | PROMIS fatigue and physical function T-scores, pain score | At diagnosis and at each review | Up to date | Baseline at intake: fatigue 71, physical function 32, pain 4; repeat at the three-month review |
| Medication safety | Medication review | At diagnosis and at each review | Completed today | Acetaminophen as needed only; no sedatives or opioids. Cholecalciferol started at a usual dose |
| Referral | Assessment for other conditions or persisting infection | At diagnosis if uncertain | Completed today | Infectious diseases consultation today; no evidence of active infection |
| Referral | ME/CFS specialist team to confirm the diagnosis and develop the care and support plan | At diagnosis (NICE 1.4.3) | Deferred | No ME/CFS specialist team is available in this region, a deviation from the protocol. Primary care confirmed the diagnosis by NICE and IOM criteria and wrote the care and support plan with the clinic occupational therapist; she will be offered a specialist service if one becomes available |
| Self-management | Energy management plan and activity and symptom diary | Every review | Completed today | Baseline set at about three hours of reclined work a day in short blocks; occupational therapist session booked |
Goal progress:
Guideline basis: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Diagnosing ME/CFS (2024); Grach SL, et al. Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Mayo Clin Proc 2023;98(10):1544-1551 (2023); Clinical Overview of Brucellosis (2024)
Follow-up: Occupational therapist energy management session next week. ME/CFS review in about ten weeks with PHQ-9, PROMIS scores, and 25-hydroxyvitamin D. Call for a flare that does not settle within a week, fever, or new back or joint pain. Next scheduled visit 2026-06-01: three-month ME/CFS energy management review. [S]